Search
Following on from the CHARGE Australasia 2024 Conference, we would like to invite: Siblings aged 18+ who have a brother or sister with CHARGE
News & Events
Professor Andrew Whitehouse on ABC720Autism researcher Professor Andrew Whitehouse was on 720 ABC Perth yesterday taking questions on child health.
News & Events
Autism research innovator shortlisted for Eureka PrizeDr Andrew Whitehouse from Perth's Telethon Institute for Child Health Research shortlisted as a finalist for the prestigious 2012 Australian Museum Eureka Prize
Research
Are autistic traits in the general population stable across development?There is accumulating evidence that autistic traits (AT) are on a continuum in the general population.
Research
Unpacking the complex nature of the autism epidemicThe etiology of autism spectrum disorders is unknown but there are claims of increasing prevalence in many countries.
Research
Do children with autism 'switch off' to speech sounds? An investigation using event-related potentialsAutism is a disorder characterized by a core impairment in social behaviour. A prominent component of this social deficit is poor orienting to speech.
Research
Evidence against poor semantic encoding in individuals with autismThis article tests the hypothesis that individuals with autism poorly encode verbal information to the semantic level of processing, instead paying greater...
Research
Autism likelihood in infants born to mothers with asthma is associated with blood inflammatory gene biomarkers in pregnancyMothers with asthma or atopy have a higher likelihood of having autistic children, with maternal immune activation in pregnancy implicated as a mechanism. This study aimed to determine, in a prospective cohort of mothers with asthma and their infants, whether inflammatory gene expression in pregnancy is associated with likelihood of future autism.
Research
Sertraline for anxiety in adults with a diagnosis of autism (STRATA): study protocol for a pragmatic, multicentre, double-blind, placebo-controlled randomised controlled trialSelective serotonin reuptake inhibitors (SSRIs) are commonly prescribed to manage anxiety in adults with an autism diagnosis. However, their effectiveness and adverse effect profile in the autistic population are not well known. This trial aims to determine the effectiveness and cost-effectiveness of the SSRI sertraline in reducing symptoms of anxiety and improving quality of life in adults with a diagnosis of autism compared with placebo and to quantify any adverse effects.